ALS Drugs: FDA May Adjust Development Recommendations In Real Time For Ongoing Programs

 
• By Sue Sutter
  
Real time
Lessons learned from activities under FDA's ALS Science Strategy may be applied in real time to ongoing development programs. • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards